Related Experiment Video
Updated: Dec 24, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
PI(3,4)P2 Signaling in Cancer and Metabolism
Luca Gozzelino1, Maria Chiara De Santis1, Federico Gulluni1
1Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
Abstract:
The phosphatidylinositide 3 kinases (PI3Ks) and their downstream mediators AKT and mammalian target of rapamycin (mTOR) are central regulators of glycolysis, cancer metabolism, and cancer cell proliferation. At the molecular level, PI3K signaling involves the generation of the second messenger lipids phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2]. There is increasing evidence that PI(3,4)P2 is not only the waste product for the removal of PI(3,4,5)P3 but can also act as a signaling molecule. The selective cellular functions for PI(3,4)P2 independent of PI(3,4,5)P3 have been recently described, including clathrin-mediated endocytosis and mTOR regulation. However, the specific spatiotemporal dynamics and signaling role of PI3K minor lipid messenger PI(3,4)P2 are not well-understood. This review aims at highlighting the biological functions of this lipid downstream of phosphoinositide kinases and phosphatases and its implication in cancer metabolism.
Insights
Phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] is a key signaling lipid in cancer metabolism. This review explores PI(3,4)P2
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Phosphatidylinositide 3-kinases (PI3Ks), AKT, and mTOR regulate critical cellular processes like metabolism and proliferation.
- PI3K signaling generates phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3] and phosphatidylinositol 3,4-bisphosphate [PI(3,4)P2] lipid messengers.
- PI(3,4)P2 is increasingly recognized for signaling roles beyond being a PI(3,4,5)P3 byproduct.
Purpose of the Study:
- To review the biological functions of the PI3K minor lipid messenger PI(3,4)P2.
- To elucidate the spatiotemporal dynamics and signaling roles of PI(3,4)P2.
- To highlight the implications of PI(3,4)P2 in cancer metabolism.
Main Methods:
- Literature review of phosphoinositide signaling pathways.
- Analysis of studies on PI(3,4)P2 cellular functions.
- Integration of findings related to PI3K, AKT, mTOR, and cancer metabolism.
Main Results:
- PI(3,4)P2 exhibits distinct cellular functions, including clathrin-mediated endocytosis and mTOR regulation, independent of PI(3,4,5)P3.
- The precise spatiotemporal dynamics of PI(3,4)P2 signaling are not fully understood.
- PI(3,4)P2 plays a significant role in cancer cell metabolism.
Conclusions:
- PI(3,4)P2 is an important signaling lipid with critical roles in cellular processes and cancer.
- Further research is needed to fully understand the dynamics and signaling mechanisms of PI(3,4)P2.
- Targeting PI(3,4)P2 pathways may offer new strategies for cancer therapy.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Abnormal Proliferation

